Akorn (AKRX): Notes From Management Meetings - Jefferies

August 29, 2016 7:40 AM EDT
Get Alerts AKRX Hot Sheet
Price: $26.74 -1.4%

Rating Summary:
    13 Buy, 8 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade AKRX Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Jefferies analyst, David Steinberg, reiterated his Buy rating on shares of Akorn (NASDAQ: AKRX) after hosting the company for two days of investor meetings. A focal point was market dynamics for AKRX’s largest product ephedrine ($200M+). This remains a very fluid situation with many factors at play.

Other key topics included AKRX’s 86 ANDA pipeline & M&A. Post these meetings, the analyst expects near term volatility as the ephedrine story plays out but the analyst likes the risk-reward profile at current levels given likely robust new product flow and potential acquisitions.

No change to the price target of $35.00

For an analyst ratings summary and ratings history on Akorn click here. For more ratings news on Akorn click here.

Shares of Akorn closed at $26.86 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Management Comments

Related Entities

Jefferies & Co

Add Your Comment